Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa
Top Cited Papers
- 1 April 2004
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 18 (6), 887-895
- https://doi.org/10.1097/00002030-200404090-00006
Abstract
A community-based antiretroviral therapy (ART) programme was established in 2001 in a South African township to explore the operational issues involved in providing ART in the public sector in resource-limited settings and demonstrate the feasibility of such a service. Data was analysed on a cohort of patients with symptomatic HIV disease and a CD4 lymphocyte count 6 Two-hundred and eighty-seven adults naive to prior ART were followed for a median duration of 13.9 months. The median CD4 lymphocyte count was 43 × 106 cells/l at initiation of treatment, and the mean log10 HIV RNA was 5.18 copies/ml. The HIV RNA level was undetectable (6 ART can be provided in resource-limited settings with good patient retention and clinical outcomes. With responsible implementation, ART is a key component of a comprehensive response to the epidemic in those communities most affected by HIV.Keywords
This publication has 13 references indexed in Scilit:
- Adherence is not a barrier to successful antiretroviral therapy in South AfricaAIDS, 2003
- Time to act: global apathy towards HIV/AIDS is a crime against humanityThe Lancet, 2002
- Survival rates after the initiation of antiretroviral therapy stratified by CD4 cell counts in two cohorts in Canada and the United StatesAIDS, 2002
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesThe Lancet, 2002
- The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up studyAIDS, 2002
- Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistanceThe Lancet, 2002
- Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug TherapyJAMA, 2001
- Confronting Global AIDS: Prevention and TreatmentAmerican Journal of Public Health, 2001
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- CD4 and total lymphocyte counts as predictors of HIV disease progressionQJM: An International Journal of Medicine, 1996